Miyase Bayraktar

1.5k total citations
43 papers, 1.0k citations indexed

About

Miyase Bayraktar is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Miyase Bayraktar has authored 43 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Miyase Bayraktar's work include Bone health and osteoporosis research (6 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Thyroid Disorders and Treatments (5 papers). Miyase Bayraktar is often cited by papers focused on Bone health and osteoporosis research (6 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Thyroid Disorders and Treatments (5 papers). Miyase Bayraktar collaborates with scholars based in Türkiye, Germany and United States. Miyase Bayraktar's co-authors include Alper Gürlek, Yusuf Bayraktar, Ferhun Balkancı, Meral Çalgünerı, Bülent Okan Yıldız, Ayla Harmancı, Neşe Çınar, Jale Karakaya, Neslihan Başçıl Tütüncü and Selçuk Dağdelen and has published in prestigious journals such as Diabetes Care, Osteoporosis International and Frontiers in Physiology.

In The Last Decade

Miyase Bayraktar

41 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miyase Bayraktar Türkiye 20 333 192 185 179 160 43 1.0k
P. S. N. Menon India 20 587 1.8× 208 1.1× 296 1.6× 125 0.7× 94 0.6× 47 1.1k
Michał Holecki Poland 17 101 0.3× 148 0.8× 233 1.3× 184 1.0× 127 0.8× 77 914
Nilgün Güvener Türkiye 20 450 1.4× 236 1.2× 123 0.7× 121 0.7× 34 0.2× 38 1.1k
Akira Kobayashi Japan 19 207 0.6× 369 1.9× 114 0.6× 221 1.2× 108 0.7× 87 1.5k
C. C. Chow Hong Kong 20 445 1.3× 208 1.1× 215 1.2× 125 0.7× 54 0.3× 29 921
Emilio González‐Reimers Spain 19 84 0.3× 132 0.7× 367 2.0× 212 1.2× 175 1.1× 59 1.2k
Yiting Xu China 17 246 0.7× 68 0.4× 202 1.1× 221 1.2× 97 0.6× 69 752
Antonio Milena Spain 12 106 0.3× 162 0.8× 197 1.1× 134 0.7× 47 0.3× 16 879
Sung Kil Lim South Korea 23 601 1.8× 240 1.3× 448 2.4× 388 2.2× 150 0.9× 109 1.7k
Bünyamin Yavuz Türkiye 21 146 0.4× 267 1.4× 145 0.8× 102 0.6× 50 0.3× 64 1.3k

Countries citing papers authored by Miyase Bayraktar

Since Specialization
Citations

This map shows the geographic impact of Miyase Bayraktar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miyase Bayraktar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miyase Bayraktar more than expected).

Fields of papers citing papers by Miyase Bayraktar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miyase Bayraktar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miyase Bayraktar. The network helps show where Miyase Bayraktar may publish in the future.

Co-authorship network of co-authors of Miyase Bayraktar

This figure shows the co-authorship network connecting the top 25 collaborators of Miyase Bayraktar. A scholar is included among the top collaborators of Miyase Bayraktar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miyase Bayraktar. Miyase Bayraktar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ünlütürk, Uğur, Tolga Yıldırım, Merve Savaş, et al.. (2024). Effect of post-transplant diabetes mellitus on cardiovascular events and mortality: a single‐center retrospective cohort study. Endocrine. 85(2). 695–703. 1 indexed citations
2.
Bayraktar, Miyase, et al.. (2021). Anthropometric measurements and serum TNF-α, IL-6 and adiponectin in type 2 diabetes. Diabetology International. 13(2). 396–406. 14 indexed citations
3.
Yıldız, Bülent Okan, Duygu Yazgan Aksoy, Ayla Harmancı, et al.. (2013). Effects of L-Thyroxine Therapy on Circulating Leptin and Adiponectin Levels in Subclinical Hypothyroidism: A Prospective Study. Archives of Medical Research. 44(4). 317–320. 11 indexed citations
4.
Bayraktar, Miyase. (2013). Serum resistin and high sensitive CRP levels in patients with subclinical hypothyroidism before and after L-thyroxine therapy. Medical Science Monitor. 19. 210–215. 24 indexed citations
5.
Berker, Mustafa, İlkay Işıkay, Dilek Berker, Miyase Bayraktar, & Alper Gürlek. (2013). Early promising results for the endoscopic surgical treatment of Cushing’s disease. Neurosurgical Review. 37(1). 105–114. 25 indexed citations
6.
Çınar, Neşe, Ayla Harmancı, Bülent Okan Yıldız, & Miyase Bayraktar. (2013). Vitamin D status and seasonal changes in plasma concentrations of 25-hydroxyvitamin D in office workers in Ankara, Turkey. European Journal of Internal Medicine. 25(2). 197–201. 42 indexed citations
7.
Akın, Şafak, et al.. (2012). Clinicopathological characteristics of patients with thyroid papillary microcarcinoma: preliminary results. 15th International & 14th European Congress of Endocrinology. 29. 1 indexed citations
8.
Okutucu, Sercan, Erkan Ayhan, Erol Tülümen, et al.. (2012). OP-281 ASSESSMENT OF THE RELATIONSHIP OF CHOLECALCIFEROL, CALCIUM CARBONATE AND ALENDRONATE TREATMENTS WITH AORTIC VALVE CALCIFICATION. International Journal of Cardiology. 155. S73–S73. 1 indexed citations
9.
Çınar, Neşe, Ayla Harmancı, Miyase Bayraktar, & Bülent Okan Yıldız. (2012). Ethinyl estradiol–drospirenone vs ethinyl estradiol–drospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome. Clinical Endocrinology. 78(3). 379–384. 14 indexed citations
10.
Harmancı, Ayla, Neşe Çınar, Miyase Bayraktar, & Bülent Okan Yıldız. (2012). Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome. Clinical Endocrinology. 78(1). 120–125. 41 indexed citations
11.
Gülçelik, Neşe Ersöz, et al.. (2011). Mortality after Hip Fracture in Diabetic Patients. Experimental and Clinical Endocrinology & Diabetes. 119(7). 414–418. 66 indexed citations
12.
Dağdelen, Selçuk, Gülşen Hasçelik, & Miyase Bayraktar. (2009). Simultaneous triple organ specific autoantibody profiling in adult patients with type 1 diabetes mellitus and their first-degree relatives. International Journal of Clinical Practice. 63(3). 449–456. 12 indexed citations
13.
Ağbaht, Kemal, Alper Gürlek, Jale Karakaya, & Miyase Bayraktar. (2009). Circulating adiponectin represents a biomarker of the association between adiposity and bone mineral density. Endocrine. 35(3). 371–379. 47 indexed citations
14.
Gürlek, Alper, Miyase Bayraktar, Çağrı Savaş, & Habip Gedık. (2009). Amputation rate in 147 Turkish patients with diabetic foot. Experimental and Clinical Endocrinology & Diabetes. 106(5). 404–409. 30 indexed citations
15.
Dağdelen, Selçuk, Mevlüt Kurt, Kadriye Aydın, & Miyase Bayraktar. (2008). Rosiglitazone-induced anasarca without heart failure: capillary leakage?. HORMONES. 7(2). 180–183.
16.
Gürlek, Alper, Miyase Bayraktar, & M. Ariyürek. (2000). Inappropriate Reference Range for Peak Bone Mineral Density in Dual-energy X-ray Absorptiometry: Implications for the Interpretation of T-scores. Osteoporosis International. 11(9). 809–813. 33 indexed citations
17.
Bayraktar, Yusuf, et al.. (1997). The cardiac evaluation of liver transplant recipients: a single center's experience.. PubMed. 29(2). 162–7. 3 indexed citations
18.
Gürlek, Alper, Veli Çobankara, & Miyase Bayraktar. (1997). Liver Tests in Hyperthyroidism: Effect of Antithyroid Therapy. Journal of Clinical Gastroenterology. 24(3). 180–183. 48 indexed citations
19.
Bayraktar, Miyase, Aydan Usman, & Z. Koray. (1994). Effect of the new somatostatin analogue SMS 201-995 on exogenously used insulin. Journal of Molecular Medicine. 72(9). 669–672. 1 indexed citations
20.
Bayraktar, Miyase, et al.. (1990). THE EFFECT OF RADIOACTIVE IODINE TREATMENT ON THYROID C CELLS. Clinical Endocrinology. 33(5). 625–630. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. S. N. Menon Breakdown of academic impact, for papers by Michał Holecki Breakdown of academic impact, for papers by Nilgün Güvener Breakdown of academic impact, for papers by Akira Kobayashi Breakdown of academic impact, for papers by C. C. Chow Breakdown of academic impact, for papers by Emilio González‐Reimers Breakdown of academic impact, for papers by Yiting Xu Breakdown of academic impact, for papers by Antonio Milena Breakdown of academic impact, for papers by Sung Kil Lim Breakdown of academic impact, for papers by Bünyamin Yavuz
Rankless by CCL
2026